Insider information

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

You are here: epigenomics > News & Investors > Insider information

Insider information

23. October 2018

Epigenomics AG successfully completes capital increase; gross proceeds of EUR 22.3 million

Read more

16. October 2018

Epigenomics AG sets subscription price at EUR 1.86 per new share

Read more

03. October 2018

Epigenomics AG plans to increase share capital with subscription rights for existing shareholders / Commitment of major shareholder to participate in planned capital increase

Read more

Press releases

07. January 2019

Epigenomics AG Announces Positive Results from Microsimulation Model

Read more

20. December 2018

Epigenomics AG Announces Initiation of a Prospective Clinical Study for Liver Cancer Detection

Read more

19. December 2018

Centers for Medicare & Medicaid Services issue official 2019 Clinical Lab Fee Schedule including Epi proColon®

Read more